Inactive

The National Institute of Allergy and Infectious Diseases, National Institutes of Health intends to negotiate on an other than full and open competition basis with Becton, Dickinson & Co. (BD), 2350 Q... The National Institute of Allergy and Infectious Diseases, National Institutes of Health intends to negotiate on an other than full and open competition basis with Becton, Dickinson & Co. (BD), 2350 Qume Drive, San Jose, CA 95131 to procure the following: BD FACSymphony A3 Special Order System – Part #660937, qty-1 Laser Coherent OBIS 488-100 LS – Part #658296, qty-1 SSC Detector Decagon – Part #1147 SO 661375D1, qty-1 BB515 Detector (505LP;515/20) – Part #1147 SO 658326P38, qty-1 BB630 Detector (600LP;610/20) – Part #1147 SO 658326P39, qty-1 BB700 Detector (690LP;710/50) – Part #1147 SO 658326P41, qty-1 BB790 Detector (770LP;780/60) – Part #1147 SO 658326P42, qty-1 Laser OBIS 637-140 LX SORP – Part #656140, qty-1 Detector Decagon w/o SSC – Part #1147 SO 661375D2, qty-1 APC Detector (650LP;670/30) – Part #1147 SO 658326P10, qty-1 Alexa 700 Detector: 690LP;710/50 – Part #1147 SO 658326P13, qty-1 APC Cy7 Detector (750LP;780/60) – Part #1147 SO 658326P14, qty-1 Laser Violet Coherent OBIS 405-100 LX – Part #653535, qty-1 Detector Decagon w/o SSC – Part #1147 SO 661375D2, qty-1 BV421 Detector (410LP;431/28) – Part #1147 SO 658326P15, qty-1 BV480 Detector (450LP;470/14) – Part #1147 SO 658326P56, qty-1 BV605 Detector (600LP;610/20) – Part #1147 SO 658326P18, qty-1 BV650 Detector (635LP;670/30) – Part #1147 SO 658326P19, qty-1 BV711 Detector (690LP;710/50) – Part #1147 SO 658326P20, qty-1 BV786 Detector (750LP;780/60) – Part #1147 SO 658326P22, qty-1 Laser System UV-G4 355-20 w/BE SORP – Part #655728, qty-1 UV Detector Decagon w/o SSC – Part #1147 SO 66136DUV, qty-1 BUV396 Detector (378/29) – Part #1147 SO 658326P25, qty-1 BUV496 Detector (450LP;515/30) – Part #1147 SO 658326P26, qty-1 BUV563 Detector (550LP;586/15) – Part #1147 SO 658326P27, qty-1 BUV661 Detector (635LP;670/30) – Part #1147 SO 658326P28, qty-1 BUV737 Detector (690LP;740/35) – Part #1147 SO 658326P29, qty-1 BUV805 Detector (770LP;820/60) – Part #1147 SO 658326P30, qty-1 Laser Coherent OBIS 561-100 LS SORP – Part #658298, qty-1 Detector Decagon w/o SSC – Part #1147 SO 661375D2, qty-1 PE w/561 Detector (570LP;586/15) – Part #1147 SO 658326P23, qty-1 PE CF594 Detector (600LP;610/20) – Part #1147 SO 658326P4, qty-1 PE Cy5 Detector (650LP;670/30) – Part #1147 SO 658326P6, qty-1 PE Cy7 Detector (750LP;780/60) – Part #1147 SO 658326P9, qty-1 BD FACSFlow Sheath Fluid 20L – Part #99-30211-00, qty-1 BD CST Beads Kit 150 Tests – Part #642412, qty-1 BD FACS Sheath Solution with Surfactant – Part #336524, qty-3 Computer Bundle Z2 G4 Win10 LSR Fortessa – Part #664104, qty-1 NEC 19In LCD Monitor – Part #652867 – Part #652867, qty-1 Coherent Connection w/Integration Kit – Part #1147 SO 66127001, qty-1 Option FACSFlow Supply Sys LSRFortessa – Part #649908, qty-1 HPS Fluorochrome Evaluation Kit – Part #566352, qty-1 High Throughput System, qty-1 BD HTS LSRFortessa – Part #647701, qty-1 FACS Shutdown Solution – Part #334224, qty-1 BD FACSDiva CS&T Research Beads Kit 50T – Part #655050, qty-1 Trade-in FACSCanto II Flow Cytometer, qty-1 This acquisition will be processed FAR Part 12 – Acquisition for Commercial Items and FAR Part 13 - Simplified Acquisition Procedures will be used for this acquisition. This acquisition will be made pursuant to the authority in FAR Part 13.501(a)(1). Only one award will be made as a result of this solicitation. This will be awarded as a firm-fixed price type of purchase order. Delivery to Bethesda, Maryland 20892 approximately ninety (90) days after receipt and acceptance of award. This requirement is to provide equipment to the Laboratory of Immunoregulation (LIR) to maintain continuity of science, data integrity, experimental compatibility between existing equipment and critical protocols, and to prevent variability in data. The LIR requires a new Becton Dickinson (BD) Special Order FACSymphony A3 Cell Analyzer to continue its longstanding research mission aimed at elucidating basic mechanisms of HIV/AIDS pathogenesis. In addition this new requirement will be employed in projects initiated by the LIR in 2020 involving COVID-19. In order to perform the experimental process concern of HIV and COVID-19 the lab is upgrading from a BD FACSCanto II flow cytometer that is reaching the end of its lifespan. The BD FACSymphony A3 Cell Analyzer will be equipped with 5 lasers, 30 parameters with 28 colors allowing the lab to utilize up to 28 different antibody/dye combinations. This is significant improvement from the current instrument that offers less antibody/dye combinations, which has become insufficient for the types of experimentation that LIR need to perform in order to make progress in their research projects. In addition, the 96 well microtiter high throughput sampler is a significant upgrade to the current instrument, which does not have the autosampler. The autosampler will increase the productivity and allow the lab to analyze tissues in a rapid way. This is essential because these tissues often degrade over time. In order to support existing research projects, to provide seamless transition to the new equipment, and to maintain experimental compatibility between existing equipment and the new equipment is to continue with the BD platform that has been used by LIR for numerous years. Procurement of a new BD instrument will allow staff to use existing protocols to avoid introducing outside variables resulting in corruption of the labs experiments leading to spending additional funding to having to start experimental process with a different platform. Switching to a different manufacturer would require development of new protocols, which would be very costly to the government. The new instrument will be housed in a Biosafety Level II/III laboratory, which no special plumbing, electrical, or special air required as modification to the laboratory is not allowed. Without this upgrade the LIR will not be able to answer the types of questions that need to be addressed in order to make progress toward the development of an HIV vaccine and to better understand basic features of COVID-19 disease. The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 6.302-1 only one source available, no substitutions possible. THIS IS NOT A SOLICITATION FOR COMPETITIVE QUOTATIONS. All responsible sources who can provide the same equipment may submit a response that could be considered by email (subject line to reference NIAID-NOI-21-2086159) to Tonia Alexander at talexander@niaid.nih.gov, by 11:00 am eastern daylight time Thursday, September 9, 2021. All information furnished must be in writing and must contain sufficient detail to allow NIAID to determine if it can meet the above specifications described herein. A determination not to compete this requirement, based upon response to this notice, is solely within the discretion of the Government. Any response received after the closing date and time of this notice will be late and will not be considered.